Your Own Cells as Medicine: The Revolution of Cell Therapy

Moving Beyond Traditional Drugs: Reprogramming the Immune System to Fight Refractory and Complex Diseases

KTI

Your Own Cells as Medicine: The Revolution of Cell Therapy

Imagine that instead of giving a patient only a drug, doctors could take some of the patient’s own cells, change them in a laboratory, and then return them to the body to fight a disease. This is the idea behind cell therapy.

One of the most advanced examples is CAR-T cell therapy, where a patient’s own T cells are genetically modified to recognize and attack certain cancer cells. The cells essentially become a living medicine.

What Is Cell Therapy?

Cell therapy is a rapidly developing field of medicine that has changed the way scientists think about treating disease. Instead of focusing only on medicines that act on the body, researchers can work with cells themselves and give them specific roles. Depending on the type of therapy, cells may be used to replace damaged cells, restore lost functions, repair tissues, or strengthen the body’s natural defenses. This approach has opened new possibilities for treating conditions that may be difficult to manage with conventional treatments. 

How Does Your Own Cell Become Medicine?

Collect — T cells are collected from the patient's blood.

Modify — The cells are genetically engineered in a specialized laboratory.

Multiply— The modified cells are grown until there are enough for treatment.

Prepare— The patient usually receives chemotherapy to prepare the body.

Infuse— The modified cells are returned to the patient's bloodstream.

Attack— The cells recognize their target and attack the cancer cells.

Why Is This Revolutionary?

Unlike traditional medicines, cell therapy can use the patient’s own cells as the treatment, allowing medicine to be more personalized.

Where Is It Being Used Today?

CAR-T therapy is already used in the United States and other countries for certain blood cancers, including leukemia, lymphoma, and multiple myeloma. It is usually used when cancer has returned (relapsed) or does not respond to treatment (refractory). Some newer treatments are now being used earlier for certain cancers.

What Is Still Being Tested?

Researchers are testing engineered CAR-T cells against solid tumors, including certain cancers in children and young adults. Phase I trials mainly focus on safety and dosage. Solid tumors are more difficult to treat because the tumor environment can prevent CAR-T cells from reaching and destroying cancer cells.

What Stage of Disease?

Already approved:

Certain relapsed or treatment-resistant blood cancers.

Currently being tested:

Advanced or metastatic solid cancers

Cancers that have returned

Cancers that do not respond to standard treatments

Rare or difficult-to-treat tumors

Is It Safe?

Cell therapy can produce remarkable responses, but it can also cause serious complications. One important complication is cytokine release syndrome (CRS), an excessive immune reaction that can cause fever, low blood pressure, and other problems. Neurological complications and serious infections can also occur with some CAR-T therapies. Therefore, these treatments require specialized centers and close monitoring.

What Could the Future Look Like?

Scientists are working to make cell therapies safer, faster, and effective against more diseases. Today, they help treat some blood cancers, and in the future, they may help treat harder-to-control cancers.

Author: Heshw Othman Hamasur